NOA TRACKER

Track Alzheimer's Disease Research Center Funding.

ADRCs lead the way in advancing science, improving care, and inspiring hope for a better future. Access verified NOA data here.

Inspiring hope through scientific discovery and improved care

0 +

Participants in AD research over the last four decades

Over 0

Years of Alzheimer's research leadership

0 +

Clinical assessments providing unparalleled longitudinal data

Alzheimer's Disease Research Centers

The Alzheimer's Disease Research Centers (ADRCs) serve as a national resource for research on Alzheimer's disease and similar related dementias. Qualifying centers conduct cutting-edge research while providing diagnostic, treatment, and care services to patients and families affected by these devastating conditions.

View NIA Data

Track FY25 distributions across Alzheimer's Disease Research Centers (ADRC)

Explore Notice of Award (NOA) release timelines with valuable added context, including application and program type, organizational traits, state or region, and historical funding data for each center.

Strategic Planning & Benchmarking

Compare your center's funding timeline against those at peer institutions to establish realistic expectations and recognize potential delays early on. Filter by application type, geographic region, or funding amount to identify patterns that may affect programs like yours.

Historical Context

See past funding totals to understand how policy changes, budget cycles, and external factors affect cancer research funding over time. Compare current delays to historical norms to determine whether challenges are temporary disruptions or systemic issues requiring sustained advocacy.

Advocacy & Communication

Use concrete data to strengthen conversations with institutional leadership, legislators, and funding agencies. When you can show that similar centers have received NOAs in a particular timeline but yours is still experiencing a lengthy delay, you have evidence to support requests for bridge funding or policy changes.

Strategic Applications

How research administrators can use this data

Frequently asked questions

 

Currently, we only track the NIA-designated Alzheimer's Disease Research Centers (ADRCs) — all centers receiving P30 funding for Alzheimer's disease research. These represent major Alzheimer's research programs in the United States and receive significant federal funding for dementia research. While there are excellent Alzheimer's research programs at other institutions, the ADRCs have a unique funding structure and reporting requirements that make them particularly suitable for this type of tracking.

We primarily track P30 Alzheimer's Disease Research Center grants since these are the core funding mechanisms for ADRCs. We don’t track every individual R01 or small grant at the moment. Our focus is on significant center-level funding when it’s substantial enough to impact operations and strategic, center-level decision making.

Our primary source is the NIH RePORTER database, which we access weekly. We also monitor NIA announcements, institutional press releases, and official NOA documents when they're publicly available. We don't rely on rumors, social media, or unofficial sources. If we can't verify information through official channels, we mark it as pending internally until we can confirm the details. This conservative approach keeps our data reliable.

We update our ADRC funding data every Saturday after the NIH RePORTER database refreshes. Unlike automated feeds that can miss nuances or contain errors, we manually verify each NOA release and cross-reference it with official sources. This means you get reliable, human-checked intelligence rather than raw data dumps. Our weekly schedule also ensures you're never more than a few days behind the latest funding announcements.

Yes, that is our intent for providing the NOA Tracker. We have provided buttons within each page that enable CSV downloads of the complete dataset, updated weekly. The download includes all the fields you see in the tracker plus some additional metadata that might be useful for analysis. You're free to use this data for internal planning, presentations to leadership, or advocacy efforts. We just ask that you credit the source if you share the data publicly or use it in publications.

In the event that an error is found, we request that you reach out to us immediately through our contact form. We take data accuracy seriously and want to correct any errors quickly. When you contact us, please include the specific grant number, the error you've identified, and any supporting documentation you can provide. We typically investigate and respond to error reports within 48 hours. Your feedback helps us maintain the quality that makes this tracker valuable for the entire community.

No, the NOA Tracker is completely free to access and use. We believe funding transparency benefits the entire Alzheimer's research community, so we don't gate the data behind paywalls or registration requirements. You can bookmark the page, download the data, and share it with colleagues without any restrictions. Our goal is to support Alzheimer's research excellence, not to create barriers to information access.

Alzheimer's research requires long-term planning and significant infrastructure investment to advance our understanding of dementia and develop treatments. When funding is delayed or uncertain, it impacts everything from hiring decisions to equipment purchases to clinical study protocols. By tracking funding patterns, ADRC administrators can plan more effectively, benchmark against peers, and advocate for predictable funding cycles. This transparency also helps the broader research community understand funding trends and challenges.

Questions? We'd love to connect.

Ask about the NOA Tracker, how we gather the data, or anything else. Our experts are standing by, ready to help.

We believe research is the greatest platform for progress.

We are passionate proponents of _______, committed to doing well by all of our stakeholders — our partners, employees, communities, the planet, and society as a whole. And we lead by example, spearheading initiatives in philanthropy, racial equality and justic, climate action and advocacy, and the ethical and humane use of technology.